ArticleEuropean urology2021

Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial.

Rafael E de Feria Cardet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.